Mitoxantrone and high-dose cytosine arabinoside in refractory acute myelogenous leukemia.
about
The treatment of acute myeloid leukemia in first relapse: a comprehensive review of the literature.Assessment of Drug Sensitivity in Hematopoietic Stem and Progenitor Cells from Acute Myelogenous Leukemia and Myelodysplastic Syndrome Ex Vivo.Mitoxantrone, etoposide, carboplatinum and ara-C combination therapy (MECA) in refractory and relapsed acute leukemia.
P2860
Mitoxantrone and high-dose cytosine arabinoside in refractory acute myelogenous leukemia.
description
1988 nî lūn-bûn
@nan
1988 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1988 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
name
Mitoxantrone and high-dose cytosine arabinoside in refractory acute myelogenous leukemia.
@ast
Mitoxantrone and high-dose cytosine arabinoside in refractory acute myelogenous leukemia.
@en
type
label
Mitoxantrone and high-dose cytosine arabinoside in refractory acute myelogenous leukemia.
@ast
Mitoxantrone and high-dose cytosine arabinoside in refractory acute myelogenous leukemia.
@en
prefLabel
Mitoxantrone and high-dose cytosine arabinoside in refractory acute myelogenous leukemia.
@ast
Mitoxantrone and high-dose cytosine arabinoside in refractory acute myelogenous leukemia.
@en
P2093
P1433
P1476
Mitoxantrone and high-dose cytosine arabinoside in refractory acute myelogenous leukemia.
@en
P2093
Andersson B
Freireich EJ
Kantarjian HM
Keating MJ
McCredie KB
Plunkett WK
Walters RS
P304
P356
10.1002/1097-0142(19880815)62:4<677::AID-CNCR2820620405>3.0.CO;2-B
P407
P577
1988-08-01T00:00:00Z